Pancreatic Cancer Research

ResearcherUt Southwestern Medical CenterActive in the last 2 years

Rolf A Brekken

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on NIH RePORTER profile ID 1952938. Sources: NIH RePORTER.

Their work

Papers
0
Trials
0
Grants
6
Labs led
2
Collaborators
7
Papers, trials and grants by year

2013: 1 grant · 2014: 1 grant · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 grant · 2020: 1 grant · 2021: none · 2022: none · 2023: 1 grant · 2024: 1 grant

Grants 6

  1. Inhibition of pleiotrophin to combat pancreatic cancer metastasis R21CA286348↗
  2. Targeted inhibition in stromal TGFβ activity in pancreatic cancer R01CA243577↗
  3. Transport of Effector T cells and Nano-DC vaccine in Breast Cancer U54CA210181↗
  4. Exploitation of RAS signaling to develop therapy and early detection strategies for PDA R01CA192381↗
  5. Axl as a target for the therapy of pancreatic cancer R21CA173487↗
  6. GPCR regulation of progenitor cells in pancreatic cancer R21CA161624↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas M Wilkie · 2 shared grants, 2013–2019 · strength 0.56
  2. Haifa Shen · 1 shared grant, 2020 · strength 0.25
  3. Jenny C-N Chang · 1 shared grant, 2020 · strength 0.25
  4. Rongfu Wang · 1 shared grant, 2020 · strength 0.25
  5. Elizabeth Mittendorf · 1 shared grant, 2020 · strength 0.25
  6. Jason B. Fleming · 1 shared grant, 2020 · strength 0.25
  7. Mauro Ferrari · 1 shared grant, 2020 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.